Lv11
30 积分 2024-04-02 加入
Approach to Resectable Biliary Cancers
52分钟前
已完结
Biliary Tract Cancers
1小时前
已完结
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China
23天前
已完结
Parity and lactation induce T cell mediated breast cancer protection
30天前
已完结
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
3个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
3个月前
已完结
Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial
3个月前
已完结
Novel Estrogen Receptor – Targeted Therapies in Hormone-Receptor Positive Breast Cancer
3个月前
已完结
Hormone therapy use and young-onset breast cancer: a pooled analysis of prospective cohorts included in the Premenopausal Breast Cancer Collaborative Group
3个月前
已完结
Hormone therapy use and young-onset breast cancer: a pooled analysis of prospective cohorts included in the Premenopausal Breast Cancer Collaborative Group
3个月前
已完结
皖公网安备34019202002308
